European Journal of Organic Chemistry
10.1002/ejoc.202100762
FULL PAPER
and brine, dried over Na
2
SO
4
and evaporated. The remaining residue was
combined organic phases were washed with saturated aqueous NaHCO
3
purified by column chromatography eluting with hexane/EtOAc 19:1 to give
2 4
and brine, dried over Na SO and evaporated. The remaining residue was
benzal chloride derivatives rac-7a (0.277 g, 0.58 mmol, 31%) and rac-7b
purified by column chromatography eluting with hexane/EtOAc 39:1 to give
benzal chloride derivatives rac- 9a (0.029 g, 0.06 mmol, 12%) and rac-9b
(0.207 g, 0.39 mmol, 78%). The resulting products were used in the next
step as a mixture.
(0.560 g, 1.05 mmol, 57%). The resulting products were used in the next
step as a mixture.
Benzal chloride rac-7a: R
1H NMR (400 MHz, CDCl
f
=0.35 (Hexane/EtOAc 19:1); m.p. 114-117 °C;
) δ=9.77 (s, 1H), 7.36 (s, 1H), 7.19 – 7.14 (m,
1
3
Benzal chloride rac-9a: R
f
=0.31 (Hexane/EtOAc 19:1); m.p. 139-141°C; H
2
(
(
H), 6.87 (s, 1H), 6.71 (s, 1H), 3.96 (dd, J = 12.4, 9.4 Hz, 1H), 3.58 – 3.35
m, 2H), 3.32 (dd, J = 14.0, 9.9 Hz, 1H), 3.16 – 2.89 (m, 4H); 13C NMR
100 MHz, CDCl ) δ=191.6, 143.6, 140.6, 138.9, 137.8, 137.2, 136.8,
35.6, 135.5, 134.5, 132.6, 131.4, 128.8, 69.0, 34.9, 34.9, 30.7, 30.0;
NMR (400 MHz, CDCl
3
) δ=9.88 (s, 1H), 7.66 (s, 1H), 7.44 (s, 1H), 6.94 (s,
1H), 6.76 (s, 1H), 6.44 (s, 1H), 4.08 (dd, J = 12.9, 9.7 Hz, 1H), 3.46 – 3.30
(m, 3H), 3.27 – 3.17 (m, 1H), 3.15 – 3.06 (m, 1H), 3.03 – 2.93 (m, 1H),
2.88 – 2.078 (m, 1H); 13C NMR (100 MHz, CDCl
3
1
3
) δ=191.9, 142.2, 140.1,
+
HRMS (APCI-TOF) m/z: Calcd for C18
2
H14Br ClO [M–Cl] 438.9094, found
140.0, 137.8, 137.5, 137.4, 137.1, 135.4, 135.3, 133.4, 129.1, 128.9, 68.8,
4
38.9095.
33.1, 32.8, 32.7, 31.8; HRMS (APCI-TOF) m/z: Calcd for C18
H
15Br
2
Cl
2
O
+
[M+H] 474.8861 found 474.8860.
Benzal chloride rac-7b: R
f
=0.54 (Hexane/EtOAc 19:1); m.p. 207-209 °C;
) δ=7.32 (s, 2H), 7.01 (s, 2H), 6.60 (s, 2H), 3.49
3.38 (m, 4H), 3.13 (ddd, J = 13.5, 9.9, 7.7 Hz, 2H), 2.97 (ddd, J = 13.5,
.9, 7.5 Hz, 2H); 13C NMR (100 MHz, CDCl
) δ=138.9, 138.4, 136.5, 134.9,
1H NMR (400 MHz, CDCl
Benzal chloride rac-9b: R
=0.44 (Hexane/EtOAc 19:1); m.p. 168-170°C;
3
f
–
9
1
1H NMR (400 MHz, CDCl
3
) δ=7.51 (s, 2H), 6.81 (s, 2H), 6.73 (s, 2H), 3.52
3
– 3.40 (m, 2H), 3.39 – 3.27 (m, 2H), 3.23 – 3.10 (m, 2H), 2.99 – 2.85 (m,
2H); 13C NMR (100 MHz, CDCl
) δ=140.2, 136.6, 136.5, 136.3, 129.1,
30.9, 128.5, 69.6, 34.9, 30.2; HRMS (APCI-TOF) m/z: Calcd for
3
+
C
18
H14Br
2
Cl
3
[M–Cl] 492.8522, found 492.8517.
128.8, 69.1, 32.6, 32.1; HRMS (ESI-TOF) m/z: Calcd for C18
Cl] 492.8522, found 492.8515.
H14Br
2
Cl
3
[M–
+
4,12-Dibromo-7,15-diformyl[2.2]paracyclophane (rac-1)
4
,15-Dibromo-7,12-diformyl[2.2]paracyclophane (rac-2)
The mixture of rac-7a and rac-7b (0.837 g, 1.63 mmol) from previous step
was dissolved in 25 mL of EtOH/H O (5:1) and the resulting solution was
refluxed for 2 h. After completion of the reaction (by monitoring TLC), the
solvent was evaporated under reduced pressure. The residue was taken
2
The mixture of rac-9a and rac-9b (0.236 g, 0.45 mmol) from previous step
was dissolved in 15 mL of EtOH/H O (5:1) and the resulting solution was
refluxed for 2 h. After completion of the reaction (by monitoring TLC), the
solvent was evaporated under reduced pressure. The residue was taken
up in CH
aqueous phase was extracted with CH
organic phases were dried over Na SO and concentrated under reduced
pressure. The crude product was purified on silica gel column using
hexane/EtOAc, (9:1) to afford 4,12-dibromo-7,15-
2
up in CH
aqueous phase was extracted with CH
organic phases were dried over Na SO and concentrated under reduced
pressure. The crude product was purified on silica gel column using
hexane/EtOAc, (9:1) to afford 4,12-dibromo-7,15-
2
Cl
2
(20mL) and the solution washed with water (20 mL). The
2
Cl (20mL) and the combined
2
2
Cl
2
(20mL) and the solution washed with water (20 mL). The
2
4
2
Cl (20mL) and the combined
2
2
4
formyl[2.2]paracyclophane (rac-1) (0.654 g, 1.55 mmol, 95%) as a white
1
solid. R
f
=0.15 (Hexane/EtOAc 19:1); m.p. 202-205 °C; H NMR (400 MHz,
formyl[2.2]paracyclophane (rac-2) (0.172 g, 0.41 mmol, 91%) as a white
1
CDCl
–
3
) δ=9.79 (s, 2H), 7.27 (s, 2H), 6.88 (s, 2H), 4.00 – 3.87 (m, 2H), 3.55
3.41 (m, 2H), 3.13 – 2.94 (m, 4H); 13C NMR (100 MHz, CDCl
) δ=191.4,
solid. R
CDCl
– 3.32 (m, 2H), 3.24 – 3.10 (m, 2H), 2.97 – 2.83 (m, 2H); 13C NMR (100
f
=0.24 (Hexane/EtOAc 19:1); m.p. 177-179 °C; H NMR (400 MHz,
3
3
) δ=9.90 (s, 2H), 7.58 (s, 2H), 6.60 (s, 2H), 4.11 – 3.98 (m, 2H), 3.45
1
43.6, 140.3, 137.6, 136.1, 135.6, 133.2, 35.2, 30.7; HRMS (APCI-TOF)
+
m/z: Calcd for C18
H15Br
O
2 2
[M+H] 420.9433, found 420.9420.
MHz, CDCl
3
) δ=191.4, 143.8, 139.9, 138.6, 135.5, 134.7, 133.6, 32.9,
+
32.8; HRMS (APCI-TOF) m/z: Calcd for C18
H15Br
O
2 2
[M+H] 420.9433,
found 420.9431.
4,15-Dibromo-7-formyl[2.2]paracyclophane (rac-8)
To a stirred solution of pseudo-meta-dibromo[2.2]paracyclophane (rac-4b)
Optical
Resolution
of
racemic
4,12-dibromo-7-
(
1.15 g, 3.14 mmol) in CH Cl (16 mL) were added a solution of TiCl (1.34
mL, 12.56 mmol) in CH Cl (2 mL) and dichloromethyl methyl ether (568
µL, 6.28 mmol) at 0 °C. The mixture was stirred at room temperature for
0 h, poured into ice and stirred for another 1 h. The two phases were
separated, and the aqueous layer was extracted with CH Cl (25 mL). The
combined organic phases were washed with saturated aqueous NaHCO
and brine, dried over Na SO and evaporated. The crude product was
purified by column chromatography eluting with hexane/EtOAc 4:1 to give
2
2
4
formyl[2.2]paracyclophane (rac-5)
2
2
rac-4,12-dibromo-7-formyl[2.2]paracyclophane (rac-5) (1.48 g, 3.76 mmol)
and (R)-phenylethylamine (10) (5.02 g, 4.14 mmol) were heated under
reflux in toluene (50 mL). The progress of the reaction was monitored by
1H NMR spectroscopy. After 16 h, the solvent was evaporated and the
crude product 11 (mixture of diastereoisomers) recrystallized twice from
2
2
2
3
2
4
hexane (10 mL, then 5 mL) giving imine (R
P
,R)-11 (de: >99%, calculated
,R) and 8.29 (R ,R) ppm
P P
,R) and 7.01 (R ,R) ppm). Yield: 0.49 g (0.99 mmol, 26%);
1
4
,15-dibromo-7-formyl[2.2]paracyclophane (rac-8) (0.940 g, 2.39 mmol,
by H NMR considering the resonance at 8.30 (S
P
P
1
76%) as a white solid. R
f
=0.42 (Hexane/EtOAc 19:1); m.p. 135-138°C; H
or 7.06 (S
(R ,R)-11; m.p. 135-138°C; [α] = –287 (c=0.54, in CH
MHz, CDCl
2
0
1
NMR (400 MHz, CDCl
3
) δ=9.87 (s, 1H), 7.60 (s, 1H), 7.12 (d, J = 7.8 Hz,
P
2
Cl
2
); H NMR (400
D
1
4
3
1
1
3
3
H), 6.72 (s, 1H), 6.52 (dd, J = 7.8, 1.8 Hz, 1H), 6.48 (d, J = 1.8 Hz, 1H),
3
) δ=8.29 (s, 1H), 7.46 (d, J = 7.7 Hz, 2H), 7.37 (t, J = 7.7 Hz,
.07 (dd, J = 13.0, 10.0 Hz, 1H), 3.40 – 3.30 (m, 2H), 3.23 – 3.13 (m, 2H),
.13 – 3.02 (m, 1H), 2.95 (ddd, J = 13.0, 10.1, 7.1 Hz, 1H), 2.76 (ddd, J =
2H), 7.30 – 7.23 (m, 1H), 7.21 (s, 1H), 7.15 (d, J = 1.8 Hz, 1H), 7.01 (s,
1H), 6.48 – 6.36 (m, 2H), 4.55 (q, J = 6.6 Hz, 1H), 3.73 (dd, J = 13.2, 9.8
Hz, 1H), 3.46 – 3.29 (m, 2H), 3.12 – 2.96 (m, 3H), 2.88 – 2.76 (m, 1H),
2.72 – 2.59 (m, 1H), 1.66 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl
δ=157.7, 145.1, 141.8, 141.3, 139.2, 138.8, 136.1, 135.4, 134.6, 133.0,
3.0, 10.1, 7.1 Hz, 1H); 13C NMR (100 MHz, CDCl
3
) δ=191.7, 143.5, 141.5,
40.2, 139.9, 138.8, 136.0, 135.5, 135.0, 133.8, 130.8, 130.7, 127.4, 34.0,
3
)
3.4, 33.4, 33.0; HRMS (APCI-TOF) m/z: Calcd for C17
H15Br
2
O [M+H]+
92.9484, found 392.9481.
131.2, 128.7, 128.6, 127.1, 126.8, 126.7, 70.8, 35.6, 35.3, 32.4, 30.7, 25.1.
Benzal chloride derivatives rac-9a and rac-9b
(S
P
,R)-11 was obtained from the first crystallization filtrate with about 70%
de
To a stirred solution of 4,15-dibromo-7-formyl[2.2]paracyclophane (rac-8)
0.197 g, 0.50 mmol) in CH Cl (5 mL) were added a solution of TiCl (213
µL, 2,00 mmol) in CH Cl (1 mL) and dichloromethyl methyl ether (724 µL,
.00 mmol) at 0 °C. The mixture was refluxed with stirring at 40 °C for 20
h, poured into ice and stirred for another 1 h. The two phases were
separated, and the aqueous layer was extracted with CH Cl (15 mL). The
(
2
2
4
P P
(R )-4,12-Dibromo-7-formyl[2.2]paracyclophane ((R )-5)
2
2
8
(
R
P
,R)-11 (0.49 g, 0.99 mmol) was hydrolyzed and separated on silica gel
column by eluting with CH Cl (R )-4,12-Dibromo-7-
formyl[2.2]paracyclophane ((R )-5) (382 mg, 0.97 mmol, 98%) was
2
2
.
P
2
2
P
5
This article is protected by copyright. All rights reserved.